MRI早期检测经皮冷冻消融后脊柱转移瘤不完全治疗
回顾性纳入2011至2017年接受脊柱骨转移瘤冷冻消融且有至少1年随访及术后4个月内脊柱MRI的患者,建立四型MRI分类并评估其诊断效能。术后MRI检测残留肿瘤的敏感度为77.3%(95%CI 62.2-88.5),特异度为85.9%(95%CI 75.0-93.4);I、II、III、IV型对应1年完全治疗率分别为100%、83.3%、35.7%、10%。
要点
- 术后中位25天MRI检测残留肿瘤敏感度77.3%、特异度85.9%。
- 四型分类中I型1年完全治疗率100%,IV型仅10%。
- 直径<25 mm且距椎管≥2 mm的转移瘤1年完全治疗率95.8%。
核心结论
- 冷冻消融后MRI有助于评估消融疗效,术后MRI分类可为预测1年完全治疗提供可靠线索。
研究设计与样本
- 回顾性纳入2011至2017年接受脊柱骨转移瘤冷冻消融、随访至少1年且术后4个月内行脊柱MRI的患者,共评估39例患者54个转移瘤,由两名独立阅片者按预设四型分类评估。
关键影像表现/征象
- 术后MRI中位延迟25天进行,按预设四型分类评估消融后改变。
诊断标准与关键数值
- 术后MRI检测残留肿瘤的敏感度为77.3%(95%CI 62.2-88.5),特异度为85.9%(95%CI 75.0-93.4)。
- I、II、III、IV型分类对应1年完全治疗率分别为100%、83.3%、35.7%、10%。
- 全部54个转移瘤1年完全治疗率为59.3%,直径<25 mm且距椎管≥2 mm的转移瘤为95.8%。
临床应用与阅片要点
- 术后中位25天行MRI可用于评估冷冻消融疗效。
- 采用四型分类预测1年完全治疗,I型完全治疗率最高、IV型最低。
- 直径<25 mm且距椎管≥2 mm的脊柱转移瘤冷冻消融后1年完全治疗率达95.8%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate post-ablation MRI for the detection of incompletely treated spinal osseous metastases (SOM) after cryoablation and to propose a post-ablation imaging classification.
METHODS: After IRB consent, all patients treated with cryoablation of SOM between 2011 and 2017 having at least 1-year minimum follow-up and a spine MRI within 4 months after cryoablation were retrospectively included. A classification of MRI images into four types was set up. The primary endpoint of our study was to assess the diagnostic performance of the post-ablation MRI. The secondary endpoints were the 1-year complete treatment rate (CTR) and complications.
RESULTS: Fifty-four SOMs in 39 patients were evaluated. Post-ablation MRI was performed with a median delay of 25 days after cryoablation. Images were evaluated by two independent readers according to the pre-established image classification. Sensitivity and specificity for the detection of residual tumor were 77.3% (95%CI = 62.2-88.5) and 85.9% (95%CI = 75.0-93.4), respectively. Types I, II, III, and IV of the classification were associated with a 1-year complete treatment in 100%, 83.3%, 35.7%, and 10% of cases, respectively. The 1-year CTR was 59.3% for all 54 metastases, and 95.8% for metastases measuring less than 25 mm and at least 2 mm or more away from the spinal canal. Two grade 3 and two grade 2 adverse events according to the CTCAE were reported.
CONCLUSIONS: MRI after cryoablation is useful for the evaluation of the ablation efficacy. The classification of post-cryoablation MRI provides reliable clues for the prediction of complete treatment at 1 year.
KEY POINTS: • MRI performed 25 days after cryoablation is useful to evaluate the efficacy. • The proposed classification provides a reliable clue for complete cryoablation. • Percutaneous cryoablation of spinal metastases is highly effective for lesions less than 25 mm in diameter and of at least 2 mm away from the spinal canal.
引用
- Gravel G, Tselikas L, Moulin B, et al. Early detection with MRI of incomplete treatment of spine metastases after percutaneous cryoablation. Eur Radiol. 2019. PMID: 30877460. doi:10.1007/s00330-019-06040-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。